FDA Approves Takeda’s EoE Therapy EOHILIA by Lilu Anderson 12.02.2024 FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.